Conjunctival malignant melanoma treated successfully with BRAF inhibitor: encorafenib plus binimetinib. Miura S, Onishi M, Watabe D, Amano H, et al. Dermatol Online J 2022;28.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Miura S, Onishi M, Watabe D, Amano H, et al. Conjunctival malignant melanoma treated successfully with BRAF inhibitor: encorafenib plus binimetinib. Dermatol Online J 2022;28.
PMID: 35499425